Researchers at Hennepin Healthcare are joining sites across the world in studying a drug that could help patients who have COVID-19.
The clinical trials now underway at Hennepin Healthcare will study hospitalized patients with severe and moderate cases of COVID-19. They'll get an IV of remdesivir, an experimental antiviral drug. It was created to treat Ebola, but wasn't effective for that disease.
[ Ссылка ]
Welcome to the official YouTube channel of KARE 11 News. Subscribe to our channel for compelling and dramatic storytelling, award winning investigations, breaking news and information you can use.
» Subscribe to KARE 11 on YouTube: [ Ссылка ]_...
» Watch more KARE 11 video: [ Ссылка ]...
» Visit KARE11.com: [ Ссылка ]
» Download our app! [ Ссылка ]
» Find KARE 11 on Facebook: [ Ссылка ]
» Follow KARE 11 on Twitter: [ Ссылка ]
» Follow KARE 11 on Instagram: [ Ссылка ]
